ANGEL ADAMS: Open Payments
NPI 1568610251 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,092 in 92 payments from 24 companies in 2025. Trend: 2023 $1,368 · 2024 $1,803 · 2025 $2,092
Food & beverage: $2,074Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $411 |
| Verona Pharma, Inc. | 16 | $340 |
| AstraZeneca Pharmaceuticals LP | 6 | $276 |
| Insmed, Inc. | 12 | $176 |
| HARMONY BIOSCIENCES LLC | 4 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| GENZYME CORPORATION | 4 | $88 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| Electromed, Inc. | 5 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
Products named: Ohtuvayre, NUCALA, Arikayce, WAKIX, DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, BRILINTA.
Industry payments across FL — which companies pay providers there.
